Skip to main content
. 2019 Apr;11(Suppl 6):S921–S928. doi: 10.21037/jtd.2019.02.86

Table 1. Revivent™ case series population and outcomes.

Patient No. ICMP Age (y) Gender NYHA pre EuroSCORE II (%) RV-LV anchors LV-LV anchors ICU stay (d) Ventilation time (h) Hospital stay (d) Intraoperative AE Outcome FU (d) NYHA at FU
1 Yes 77 F III 43.05 1 1 5 4 12 Discharged 274 I
2 Yes 60 M IV 32.24 3 1 2 17 11 Discharged 262 II
3 Yes 71 M III 39.44 2 1 1 4 9 Discharged 210 I
4 Yes 77 M IV 43.59 2 1 1 3 23 Discharged 185 I
5 Yes 72 M III 40.12 2 1 22 35 41 Sternotomy for bleeding Discharged 165 II
6 Yes 69 M III 38.08 2 1 4 4 14 Discharged 135 I
7 Yes 78 F IV 49.76 2 1 20 18 45 Discharged 104 II

AE, adverse event; F, female; d, days; FU, follow-up; h, hours; ICMP, ischaemic cardiomyopathy; ICU, intensive care unit; y, years; M, male; LV, left ventricle; NYHA, New York Heart Association functional class; RV, right ventricle.